8-Isoprostane in nasally exhaled breath condensate in different pediatric lung diseases

Latzin, P; Beck-Ripp, J; Hartl, D; Bartenstein, A; Noss, J; Griese, Matthias (2007). 8-Isoprostane in nasally exhaled breath condensate in different pediatric lung diseases. European journal of medical research, 12(1), pp. 21-5. München: I. Holzapfel

Full text not available from this repository.

OBJECTIVE: Increased levels of 8-isoprostane were found in various human lung diseases suggesting 8-isoprostane as a marker of pulmonary oxidative stress in vivo. The exact role in pediatric lung diseases has not been defined yet. The goal of this study was to clarify the role of 8-isoprostane in nasally exhaled breath condensate as possible marker of oxidative stress in children with different lung diseases. METHODS: Levels of 8-isoprostane were measured in nasally exhaled breath condensate of 29 cystic fibrosis patients, 19 children with a history of wheezing episodes, 8 infants with acute respiratory tract infection and 53 healthy subjects using a specific enzyme immunoassay. RESULTS: Levels of 8-isoprostane did neither discriminate between different disease groups nor correlate with lung function in cystic fibrosis patients. CONCLUSIONS: Levels of 8-isoprostane in nasally exhaled breath condensate do not reflect oxidative stress in children with different lung diseases.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
UniBE Contributor:	Latzin, Philipp
ISSN:	0949-2321
ISBN:	17363354
Publisher:	I. Holzapfel
Language:	English
Submitter:	Anette van Dorland
Date Deposited:	04 Oct 2013 14:55
Last Modified:	05 Dec 2022 14:17
PubMed ID:	17363354
Web of Science ID:	000244112500004
URI:	https://boris.unibe.ch/id/eprint/23365 (FactScience: 41631)